These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Melanosis after prolonged chlorpromazine therapy. Robins AH S Afr Med J; 1975 Aug; 49(37):1521-4. PubMed ID: 1162531 [TBL] [Abstract][Full Text] [Related]
6. Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy. Forrest FM; Snow HL; Erickson G; Geiter CW; Laxson GO Proc West Pharmacol Soc; 1966; 9():18-20. PubMed ID: 5958492 [No Abstract] [Full Text] [Related]
7. Metabolic studies of chlorpromazine induced hyperpigmentation of the skin in psychiatric patients. Bolt AG; Forrest IS Agressologie; 1968; 9(2):201-7. PubMed ID: 5675487 [No Abstract] [Full Text] [Related]
17. How to diagnose and treat coronary artery disease in the uraemic patient: an update. Elsner D Nephrol Dial Transplant; 2001 Jun; 16(6):1103-8. PubMed ID: 11390705 [No Abstract] [Full Text] [Related]
18. Pigmentation after long-term topical use of adrenaline compounds. Mooney D Br J Ophthalmol; 1970 Dec; 54(12):823-6. PubMed ID: 5517425 [No Abstract] [Full Text] [Related]
19. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years). Goldman D Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486 [No Abstract] [Full Text] [Related]